Randox host Open University students at state-of-the-art Randox Science Park
Randox host Open University students at state-of-the-art Randox Science Park
On Wednesday 15th November, Randox hosted a site visit at its state-of-the-art Randox Science Park in Antrim for Open University (OU) students who are studying a range of subjects including Business, Science, Engineering and Software Development.
Randox is a global leader in healthcare diagnostics, pioneering innovative technologies with major focus in research and development. Their products and services are used in hospitals, clinical, research and molecular laboratories, food testing, forensic toxicology, life sciences, and veterinary laboratories worldwide.
The visit allowed the students the opportunity to experience real life lab experiments in the Research and Development department and the Design Engineering department. They also had the opportunity to tour the different IT departments and see how the operations of a large company work.
Sarah Nicol who is studying for a BSc (Honours) in Computing and IT said:
“It was interesting to hear about the full scope of work taking place within the Randox Science Park and the level of investment confirms that there is a bright future here as an employee. The training and opportunities available were much wider than I had realised.”
Joanne King who is studying for a BSc (Honours) in Health Sciences said:
“I found the visit interesting and informative. I enjoyed meeting and hearing from the current Open University students and what they were getting involved with during their placements at Randox. I certainly found the experience motivating to complete my course as opportunities may be possible with Randox.”
The students were then able to hear from two OU students who are currently on a placement with Randox: Jenny Hope who is studying BSc (Hons) in Health Sciences and Aurelija Gainaite who is studying BSc (Hons) in Natural Sciences. They are both on a one-year placement with Randox and shared with the students the importance of gaining relevant work experience in a chosen field and the potential opportunities it can lead to.
Jolene Carey, Human Resource Officer from Randox said:
“We were delighted to host The Open University students at Randox – this was a great opportunity for students to gain a valuable insight into the range of different departments within the company and to experience how they work together. We were delighted that OU students Jenny and Aurelija were able to talk directly to their fellow students and explain the benefits of gaining a placement opportunity. We look forward to continuing to develop our relationship with The Open University.”
For further information, please contact our Randox PR team by emailing randoxpr@randox.com or by phoning 028 9442 2413
Randox Science Park partners with St. John Ambulance to provide emergency health response to Antrim
St. John Ambulance and global healthcare diagnostics company Randox have today announced an innovative new partnership to enhance the services provided by the first aid organisation in the Antrim area.
The Antrim unit of St. John Ambulance has moved its fleet of vehicles into Randox’s new headquarters, the Randox Science Park, to be able to provide its services from a central location in Antrim.
In addition to the new labs, offices and manufacturing space which have so far been installed at the former Massereene Barracks, St. John Ambulance will also now form part of the Randox’s Science Park renovation plans.
Dr Peter FitzGerald, Founder and Managing Director of Randox Laboratories, commented;
“It is particularly fitting that we are now working with St. John Ambulance, given that both of our organisations are built upon a commitment to improve health and wellbeing. We’re delighted to be able to offer space for the organisation’s fleet of ambulances, and look forward to working closely with them as we enter the next phase of our Randox Science Park renovation plans.”
As part of the partnership between Randox and St. John Ambulance, St. John’s will be offering first aid training to staff within the healthcare diagnostics firm through its corporate training team.
On moving the Antrim fleet of St. John Ambulances to the Randox Science Park, Alan McClean, Unit Leader for St. John Ambulance Antrim division, said;
“Working with an organisation as reputable as Randox, from a location as central within Antrim as the Randox Science Park, will not only ensure prompt emergency response times, but will also enhance the services we offer. We want everyone in Northern Ireland to be first aid trained and to be able to receive first aid from those around them. Moving our Antrim fleet of ambulances to the Randox Science Park brings us one step closer to delivering on that aim.”
For further information, please contact our Randox PR team by emailing randoxpr@randox.com or by phoning 028 9442 2413
Alan McClean, Unit Leader of St. John Ambulance Antrim division, and Robert Huddleston, from the Randox Science Park Management Team
Cutting-edge research and testing centre opens at Randox Science Park
Following the success of the first ever Randox Health Grand National, global health diagnostics company Randox has today announced the official opening of its new central laboratory, Randox Clinical Laboratory Services (RCLS), at the recently acquired Randox Science Park in Antrim, Northern Ireland.
Situated at this new state of the art biohub, the RCLS accredited lab now houses Randox’s latest blood screening equipment – the pioneering Evolution machine. This new technology enables the labs to conduct a full range of niche and standard research testing, as well as current health testing for the company’s Randox Health division, which offers the world’s most comprehensive full body health analysis.
Research areas at the newly accredited laboratory include but are not exclusive to cancer, fertility, heart, inflammation, stroke and kidney health, both in-house and collaboratively with external organisations. Current and past collaborations include an Acute Kidney Injury Study with the Royal Victoria Hospital, a Bladder Cancer Study in partnership with Queen’s University Belfast and The Belfast Trust, a Stroke and Brain Injury study with Cambridge University, and key partnerships with a number of major pharmaceutical companies.
A staggering 222 clinical diagnostic tests are currently run routinely with the lab, with more tests pending accreditation in the coming months.
Ann-Marie Jennings, Laboratory Manager for Randox Clinical Laboratory Services, explained that the new facilities will allow RCLS to increase their output and enter new markets;
“Randox Clinical Laboratory Services has been operational for a number of years in our headquarters in Crumlin, near the Belfast International Airport. Now that we have moved to our new, purpose-built labs in the Randox Science Park, we have the ability to increase the output of both our health testing and our research testing. This involves expanding our team of experienced scientists, working towards further accreditations and furthermore setting up independent labs in Dubai, LA, Holywood and Liverpool in addition to our current labs in Antrim and London.”
Thanks to the new Randox Science Park facilities, the company will now be able to provide an increasingly wide range of testing services to Biotechnology and In Vitro Diagnostic companies, and will deliver to pharmaceutical companies the testing services required to support their drug development projects, in addition to the testing provided to research organisations,
With the ability to conduct an unrivalled range of health testing – haematology, biochemistry and immunoassay – all under one roof, the laboratory offers unparalleled support services to the dynamic and growing healthcare industry. With a greater understanding of human complexity, pharmaceutical companies are now focusing on developing safer drugs tailored to specific patient groups or sub-groups and the expansion plans in motion at RCLS will help these organisations bring new drugs to market faster.
Ann-Marie continued;
“On our patented Randox Biochip Array Technology we can customize bespoke testing platforms based on the requirements of each drug development project, which can be a challenging process. From initial product development to clinical trial stages there can be a number of barriers and time constraints before drugs are successfully released to the public. We’re confident that our newly enhanced capabilities will benefit patients suffering from conditions in most need of research by offering pharmaceutical companies at the forefront of pioneering research, with the latest technological developments.”
For more information about RCLS please contact Randox PR on 028 9442 2413 or email RandoxPR@randox.com
Secretary of State Rt Hon James Brokenshire MP visits Randox Science Park
On Monday 21st November, Secretary of State for Northern Ireland, Rt Hon James Brokenshire MP, visited our new Randox Science Park facility.
The visit was part of the Mr Brokenshire’s recently established Business Advisory Group sectoral meetings, of which the Life Science sector is a key stakeholder.
Following the visit, the Secretary of State said:
“I was absolutely delighted to visit the very impressive facilities at the Randox Science Park, in what used to be Massereene Barracks. During my tour of the site, I was struck by the powerful symbolism of what used to be the defence estate of the old Northern Ireland to what has now been transformed into world class laboratories and life sciences facilities. This showcases Northern Ireland as a leading contributor in the world of knowledge economy, and this is an area which I am confident will continue to grow.
“My visit here is to help re-affirm the Government’s commitment to do whatever is needed to safeguard the economy and forge a new global role for ourselves as we leave the European Union. The UK Government remains committed to making this country the best place in Europe to own and grow a business and to building a stronger economy that works for everyone.”
Dr Peter FitzGerald, Managing Director of Randox, said:
“We were delighted to welcome the Rt Hon James Brokenshire MP to our new Randox Science Park in Antrim, and we are encouraged by the Government’s support for the creation of a positive business environment. Since 1982 we have championed Northern Ireland and the very talented people who work with us. Our commitment to a positive future is perfectly illustrated by the evolution of this site from former army barracks to state-of-the-art biotechnology hub.
“As an innovation-led company, these revolutionary facilities are fundamental to enable us to develop more accurate and sensitive diagnostic capabilities and promote preventive healthcare globally. It will also contribute significantly to supporting the Northern Ireland economy with the creation of new jobs and increased exports. This is a significant investment, which markets not only a dynamic Randox to the world but also a positive Northern Ireland.”
For more information about the Secretary of State’s visit to the Randox Science Park please contact our PR team via email: randoxpr@randox.com
Randox unveils Future of Diagnostics Technology at Annual Global Distributorsā Conference
The future of diagnostic healthcare has been unveiled at the Randox Science Park in Antrim, as the company’s annual global distributors’ conference gets underway. Delegates from more than 90 countries are taking part in the world-leading healthcare firm’s three-day event at the Hilton Hotel in Templepatrick.
As well as discussions about developments in reagents and quality control products, participants enjoyed demonstrations of Randox’s patented Biochip Array Technology and its extensive range of analysers from the RX Series.
Melansha Fernando from Alpha and Omega Diagnostics in Sri Lanka said,
“Randox has released so many new products recently that laboratories in my country are increasingly interested in what it can offer. As a result I felt it important to come here to learn more about the new technologies. The truly global nature of the company has been impressed upon me after meeting colleagues from so many different countries – I’m delighted to have been able to take part.”
Speaking at the conference, Dr. Peter Fitzgerald said,
“All exporters are aware of the considerable challenges we must overcome in order to do business in the global market but year on year our teams across the world have helped to drive our success. One of the biggest challenges Randox faces is the one we put to ourselves, to deliver truly transformative technologies and improve health worldwide. We recently celebrated our £1 billionth sale and we now look to build on that achievement and accelerate our rate of growth. All of our profits go straight to either R&D, or the development of our infrastructure, so strong growth is key to our goal of revolutionising diagnostics and saving lives across the world.”
Susan Hammond, Global Reagents Sales Manager said,
“It is a pleasure to see the diversity of our distributors gathered together in one room, and recognize how far we have come as an international company. We dedicated Thursday to focusing on building relationships with our worldwide distributors to ensure that they attain the best product knowledge available. Over 100,000 end users employ Randox products and every second of every day 80 Randox tests are used across the world, and it is vital our distributors are kept up to date with every new development.”
For more information on the Distributors’ Conference contact Amy in our PR Team by calling 028 9445 1016 or email amy.mcilwaine@randox.com
Randox Strengthens Regional Commitment with Expansion Plans in County Antrim
- £161m investment including £29m capital project and creation of 540 jobs
- Next generation medical diagnostics manufacturing facility
- World leading R&D into conditions such as cancer, stroke, heart disease, neurodegenerative disorders, sepsis, STIs, aspirin resistance and respiratory infections
- Randox Science Park to complement Randox Teoranta’s #Dungloe2020 expansion
“This investment and expansion in County Antrim, combined with our plans for Randox Teoranta in Donegal, provides us with an extraordinary regional footprint, which will be the foundation of our global development and which will fuel our endeavours to improve health worldwide…”
Global medical diagnostics company Randox, has unveiled its plans for a futuristic manufacturing and R&D facility in County Antrim. The £161 million project, which includes a £29 million capital investment for the redevelopment of the site, will lead to the creation of 540 high value job opportunities, over the next four years.
Randox which leads in the research, development and manufacture of pioneering medical tests and cutting edge diagnostic equipment, recently revealed its plans to upgrade Randox Teoranta, in Donegal with a €25m investment, which would also see employment at the Dungloe site increase from 66 to 540 by 2020.
The award-winning biotechnology firm, with headquarters in Crumlin, County Antrim, recently purchased a 47 acre site in Antrim, which will be redeveloped to house a new centre of manufacturing and R&D, named Randox Science Park.
Randox Science Park, will complement Randox manufacturing operations in County Donegal, Manchester, India and the USA. Randox has a range of 2000 products, including advanced diagnostic tests, quality control sera, analysers and the company’s revolutionary BioChip Array Technology; the vast majority will be produced between Co Donegal and Co Antrim.
This considerable investment will accelerate the development of new products into a wide range of clinical needs, such as various cancer, stroke, heart disease and neurodegenerative disorders, through more efficient, high specification manufacturing and the provision of state-of-the-art R&D laboratories.
The site will also feature a Transformative Healthcare Centre from the Randox Health division; giving the public direct access to Randox’s ground-breaking diagnostic tests, as well as offering private GP appointments and specialist clinics, run by some of the North of Ireland’s chief medical consultants.
At a launch event today, Randox showcased its plans for Randox Science Park. Guests including Northern Ireland’s First Minister, Peter Robinson, Deputy First Minister, Martin McGuinness and Enterprise Minister, Arlene Foster, were briefed on the company’s impact on global health and vision for the future.
Speaking at the event, Randox Managing Director, Dr Peter FitzGerald said:
“The creation of Randox Science Park is fundamental to Randox meeting the health challenges facing populations across the world. We are an innovation led company, focusing more than 30 years of skills and experience on delivering accurate, rapid and quality diagnostics across a range of clinical disciplines; from stroke and heart disease, to cancer, neurodegenerative disorders, respiratory infections and so on. We must continue innovating, through our people, through our knowledge and through our technology; Randox Science Park gives us the platform we need to do this.
“This investment and expansion in County Antrim, combined with our plans for Randox Teoranta in Donegal, provides us with an extraordinary regional footprint, which will be the foundation of our global development and which will fuel our determination to improve health worldwide. It is about the future of diagnostic medicine; we are beginning 2015 as we mean to continue.”
Meanwhile the first recruitment drive for the #Dungloe2020 expansion of Randox Teoranta, which has backing from Údarás na Gaeltachta continues. The company is keen to hear from those in life sciences, medical device engineering and software; with a particular focus on software developers and testers, embedded software engineers, those with backgrounds in mechanical design as well as electronic & electrical engineers. For more information on the world-class career opportunities available at Randox Teoranta please email recruitment@randoxteoranta.com
Randox puts British Biotechnology on World Map with New Randox Science Park
- £161m investment including £29m capital project and creation of 540 jobs
- Next generation medical diagnostics manufacturing facility
- World leading R&D into conditions such as cancer, stroke, heart disease, neurodegenerative disorders, STIs, aspirin resistance, sepsis and respiratory infections
“This investment and expansion reinforces our dedication to improving health worldwide…”
Global medical diagnostics company Randox, has unveiled its plans for a futuristic manufacturing and R&D facility in the UK. The £161 million project, which includes a £29 million capital investment for the redevelopment of the site, will accelerate the development of new products into a wide range of clinical needs, such as various cancers, stroke, heart disease and neurodegenerative disorders, through more efficient, high specification manufacturing and the provision of state-of-the-art R&D laboratories.
Randox leads in the research, development and manufacture of pioneering medical tests and cutting edge diagnostic equipment, with customers in clinical, toxicology, veterinary and food safety markets in more than 145 countries.
The award-winning biotechnology firm, with headquarters in Crumlin, County Antrim, recently purchased the former British Army base at Massereene, in Antrim town, which will be redeveloped to house the new centre of manufacturing and R&D, now renamed, Randox Science Park.
Randox Science Park will become the company’s prime manufacturing site, complementary to its manufacturing operations in Manchester, Republic of Ireland, India and the USA. Randox has a range of more than 2000 products, including advanced diagnostic tests, quality control sera, analysers and the company’s revolutionary BioChip Array Technology; many of which will be produced at this next generation facility.
This considerable investment will also lead to the creation of 540 high value job opportunities, over the next four years.
In addition, the site will feature a Transformative Healthcare Centre from the Randox Health division; giving the public direct access to Randox’s ground-breaking tests, as well as offering private GP appointments and specialist clinics, run by some of the UK’s chief medical consultants.
At a launch event today, Randox showcased its plans for Randox Science Park. Guests including Northern Ireland’s First Minister, Peter Robinson, Deputy First Minister, Martin McGuinness and Enterprise Minister, Arlene Foster, were briefed on the company’s impact on global health and vision for the future.
Speaking at the event, Randox Managing Director, Dr Peter FitzGerald said:
“The creation of Randox Science Park is fundamental to Randox meeting the health challenges facing populations across the world. We are an innovation led company, focusing more than 30 years of skills and experience on delivering accurate, rapid and quality diagnostics across a range of clinical disciplines; from stroke and heart disease, to cancer, neurodegenerative disorders, respiratory infections and so on. We must continue innovating, through our people, through our knowledge and through our technology; Randox Science Park gives us the platform we need to do this.
“Randox innovation underpins our achievements, allows us to diversify, allows us to target fresh markets and fuels our exports and Randox Science Park will be at its core. This investment and expansion reinforces our dedication to improving health worldwide and our commitment to the UK economy. It is about the future of diagnostic medicine, we are beginning 2015 as we mean to continue.”
The expansion includes the creation of manufacturing, scientific and engineering opportunities on a major scale, as well as business support posts; the investment will also grow Randox’s sales and marketing capabilities. In addition, the 540 new jobs, with an average salary of £30k per year will generate £16.2 million in annual salaries, representing a significant boost to the UK economy.
The company said it was already engaging with universities across the UK, to access high calibre graduates for the world class opportunities at Randox Science Park.
Regional development agency, Invest Northern Ireland is supporting the £29m Randox capital redevelopment of the site, with an investment of £4.7 million.
